DE69901062T2 - Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung - Google Patents

Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung

Info

Publication number
DE69901062T2
DE69901062T2 DE69901062T DE69901062T DE69901062T2 DE 69901062 T2 DE69901062 T2 DE 69901062T2 DE 69901062 T DE69901062 T DE 69901062T DE 69901062 T DE69901062 T DE 69901062T DE 69901062 T2 DE69901062 T2 DE 69901062T2
Authority
DE
Germany
Prior art keywords
pharmaceutical form
active principle
multiparticular
production
controlled
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69901062T
Other languages
English (en)
Other versions
DE69901062D1 (de
Inventor
Edouard Gendrot
Gerard Cousin
Francoise Ragot
Marie-Christine Clee-Bouvet
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ethypharm SAS
Original Assignee
PROGRAPHARM CHATEAUNEUF EN THY
Laboratories Prographarm SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by PROGRAPHARM CHATEAUNEUF EN THY, Laboratories Prographarm SA filed Critical PROGRAPHARM CHATEAUNEUF EN THY
Publication of DE69901062D1 publication Critical patent/DE69901062D1/de
Application granted granted Critical
Publication of DE69901062T2 publication Critical patent/DE69901062T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5073—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings
    • A61K9/5078—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals having two or more different coatings optionally including drug-containing subcoatings with drug-free core
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DE69901062T 1998-05-20 1999-05-20 Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung Expired - Lifetime DE69901062T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9806384A FR2778848B1 (fr) 1998-05-20 1998-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation
PCT/FR1999/001201 WO1999059557A1 (fr) 1998-05-20 1999-05-20 Forme pharmaceutique multiparticulaire a liberation programmee et pulsee et son procede de preparation

Publications (2)

Publication Number Publication Date
DE69901062D1 DE69901062D1 (de) 2002-04-25
DE69901062T2 true DE69901062T2 (de) 2002-10-31

Family

ID=9526556

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69901062T Expired - Lifetime DE69901062T2 (de) 1998-05-20 1999-05-20 Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung

Country Status (25)

Country Link
EP (1) EP1077687B1 (de)
JP (1) JP2002515423A (de)
KR (1) KR100583065B1 (de)
CN (1) CN1186014C (de)
AT (1) ATE214598T1 (de)
AU (1) AU758299B2 (de)
BG (1) BG64764B1 (de)
BR (1) BR9910606A (de)
CA (1) CA2333188C (de)
DE (1) DE69901062T2 (de)
DK (1) DK1077687T3 (de)
ES (1) ES2173739T3 (de)
FR (1) FR2778848B1 (de)
GE (1) GEP20022750B (de)
HK (1) HK1033271A1 (de)
HU (1) HU224193B1 (de)
IL (1) IL139774A (de)
MX (1) MXPA00011364A (de)
NO (1) NO330501B1 (de)
NZ (1) NZ508392A (de)
PL (1) PL192950B1 (de)
PT (1) PT1077687E (de)
TR (1) TR200100107T2 (de)
WO (1) WO1999059557A1 (de)
ZA (1) ZA200006768B (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8071128B2 (en) 1996-06-14 2011-12-06 Kyowa Hakko Kirin Co., Ltd. Intrabuccally rapidly disintegrating tablet and a production method of the tablets
US9358214B2 (en) 2001-10-04 2016-06-07 Adare Pharmaceuticals, Inc. Timed, sustained release systems for propranolol
US8367111B2 (en) 2002-12-31 2013-02-05 Aptalis Pharmatech, Inc. Extended release dosage forms of propranolol hydrochloride
CA2529984C (en) 2003-06-26 2012-09-25 Isa Odidi Oral multi-functional pharmaceutical capsule preparations of proton pump inhibitors
US10624858B2 (en) 2004-08-23 2020-04-21 Intellipharmaceutics Corp Controlled release composition using transition coating, and method of preparing same
US8747895B2 (en) 2004-09-13 2014-06-10 Aptalis Pharmatech, Inc. Orally disintegrating tablets of atomoxetine
US9884014B2 (en) 2004-10-12 2018-02-06 Adare Pharmaceuticals, Inc. Taste-masked pharmaceutical compositions
NZ709754A (en) 2004-10-21 2017-02-24 Adare Pharmaceuticals Inc Taste-masked pharmaceutical compositions with gastrosoluble pore-formers
AU2013273835B2 (en) * 2005-05-02 2016-07-07 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US9161918B2 (en) * 2005-05-02 2015-10-20 Adare Pharmaceuticals, Inc. Timed, pulsatile release systems
US10064828B1 (en) 2005-12-23 2018-09-04 Intellipharmaceutics Corp. Pulsed extended-pulsed and extended-pulsed pulsed drug delivery systems
US10960077B2 (en) 2006-05-12 2021-03-30 Intellipharmaceutics Corp. Abuse and alcohol resistant drug composition
WO2008136016A1 (en) * 2007-05-08 2008-11-13 Medreich Limited A stable controlled release oral solid dosage form composition and a process thereof
MX2012006240A (es) 2009-12-02 2012-10-03 Aptalis Pharma Ltd Microcapsulas de fexofenadina y composiciones que contienen las mismas.
FR2999432B1 (fr) 2012-12-17 2014-12-12 Ethypharm Sa Comprimes orodispersibles obtenus par compression moulage

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2558396B2 (ja) * 1990-06-28 1996-11-27 田辺製薬株式会社 放出制御型製剤
US5567441A (en) * 1995-03-24 1996-10-22 Andrx Pharmaceuticals Inc. Diltiazem controlled release formulation
FR2754710B1 (fr) * 1996-10-22 1998-12-31 Prographarm Lab Procede de preparation d'une forme pharmaceutique multiparticulaire a liberation controlee plurisequentielle

Also Published As

Publication number Publication date
NO20005838L (no) 2001-01-10
BG104963A (en) 2001-07-31
AU3830299A (en) 1999-12-06
NZ508392A (en) 2002-09-27
PL192950B1 (pl) 2006-12-29
FR2778848B1 (fr) 2001-11-23
IL139774A (en) 2005-09-25
AU758299B2 (en) 2003-03-20
WO1999059557A1 (fr) 1999-11-25
CA2333188A1 (fr) 1999-11-25
IL139774A0 (en) 2002-02-10
FR2778848A1 (fr) 1999-11-26
DK1077687T3 (da) 2002-06-17
MXPA00011364A (es) 2008-09-09
NO20005838D0 (no) 2000-11-17
HUP0102027A2 (hu) 2002-03-28
KR100583065B1 (ko) 2006-06-08
ATE214598T1 (de) 2002-04-15
BG64764B1 (bg) 2006-03-31
CN1186014C (zh) 2005-01-26
CN1305371A (zh) 2001-07-25
PL344314A1 (en) 2001-10-22
CA2333188C (fr) 2010-07-06
JP2002515423A (ja) 2002-05-28
HK1033271A1 (en) 2001-08-24
ZA200006768B (en) 2001-11-20
DE69901062D1 (de) 2002-04-25
NO330501B1 (no) 2011-05-02
HU224193B1 (hu) 2005-06-28
BR9910606A (pt) 2001-10-02
GEP20022750B (en) 2002-08-26
HUP0102027A3 (en) 2002-12-28
EP1077687A1 (de) 2001-02-28
EP1077687B1 (de) 2002-03-20
TR200100107T2 (tr) 2001-06-21
ES2173739T3 (es) 2002-10-16
KR20010052370A (ko) 2001-06-25
PT1077687E (pt) 2002-09-30

Similar Documents

Publication Publication Date Title
DE69901062T2 (de) Multipartikuläre pharmazeutische form mit gesteuerter und gepulster wirkstoffabgabe und verfahren zu deren herstellung
JPH09500866A (ja) 多粒状物の脈動性投薬システム
KR860002271A (ko) 조절되게 방출되게끔(controlled-release) 코오팅된 조제학상의 제제와 그 제제의 제조방법
ATE281156T1 (de) Verfahren zur herstellung eines tabletts mit kontrollierter freisetzung mit der verwendung von einem porenbildenden agens in der beschichtung
EP0650353A4 (de) Angenehm schmeckende pharmazeutische zusammensetzungen.
ATE342306T1 (de) Polymere zusammensetzung zur lösung von schwer wasserlöslichen medikamenten und verfahren zu deren herstellung
CA2351814A1 (en) Taste masked pharmaceutical particles
KR910005875A (ko) 미노시클린을 위한 일일-1회 투여 제약학적 조달 계 및 그의 제조방법
WO1997006787A3 (en) Controlled release products
IL78895A (en) Controlled release implant composition for macromolecular drugs
CA2561109A1 (en) Gastric retention system
DE60036874D1 (de) Pellet formulierung mit gesteuerter freisetzung
ATE358160T1 (de) Ph-responsive biologisch abbaubare polymilchsäurederivate, die polymermicellen bilden, und deren verwendung zur zufuhr von schlecht wasserlöslichen arzneistoffen
WO1999047130A1 (de) Nanopartikel, verfahren zu ihrer herstellung und ihre verwendung
AU4693485A (en) Sustained release drug in ter polymer coat (pvc and pvacand pvom)
DE60022332D1 (de) Ketoprofen mikrogranulat, verfahren zur herstellung desselben sowie pharmazeutische zusammensetzungen
EP0616802A4 (de) Orale zubereitung zur freisetzung im unteren verdauungstract.
ATE23266T1 (de) Pharmazeutische produkte in formen mit verzoegerter abgabe und verfahren an deren herstellung.
SE8803822A (de)
ATE531360T1 (de) Mikrokügelchen mit verzögerter freisetzung und verfahren zu ihrer herstellung
Nath et al. Design, development, and optimization of Sterculia gum‐based tablet coated with chitosan/eudragit RLPO mixed blend polymers for possible colonic drug delivery
SE9903879D0 (sv) Multipor food protection
DE60125226D1 (de) Verfahren zur herstellung von partikelförmigen polymerisaten
WO2001051031A3 (en) Enteric coated pharmaceutical formulation
WO2000001363A3 (en) Enteric coated pharmaceutical formulation

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: ETHYPHARM, S.A., HOUDAN, FR

8328 Change in the person/name/address of the agent

Representative=s name: PFENNING MEINIG & PARTNER GBR, 80339 MUENCHEN

8328 Change in the person/name/address of the agent

Representative=s name: MAIWALD PATENTANWALTSGESELLSCHAFT MBH, 80335 MUENC